# Neurocrine Biosciences Inc: Form 8-K, filed May 23, 2024

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: 8-K
- Filed: 2024-05-23
- Accepted by EDGAR: May 23, 2024, 16:01 ET
- Period: 2024-05-22
- Accession: 0000914475-24-000140
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/nbix-20240522.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447524000140/nbix-20240522.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0000914475-24-000140. Last ingested by Listed: Nov 3, 2026, 22:38 ET. No prices; not investment advice.